The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry

NCT03479437 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 303

Last updated 2021-05-04

No results posted yet for this study

Summary

A voluntary prospective study that will allow registration and follow-up of individuals with MC4R pathway genetic obesity.

Conditions

  • Genetic Forms of Extreme Obesity

Sponsors & Collaborators

  • Rhythm Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Ihuoma Eneli · Nationwide Children's Hospital

  • Liz Stoner · Rhythm Pharmaceuticals, Inc.

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-15
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03479437 on ClinicalTrials.gov